Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Ashok Soota launches SKAN Medical research trust for Ageing and Neurological disorders, Commits Rs. 200 Cr investment
  • USA - English

SKAN_Logo

News provided by

SKAN

05 Apr, 2021, 09:35 IST

Share this article

Share toX

Share this article

Share toX

BENGALURU, India, April 5, 2021 /PRNewswire/ -- Ashok Soota today announced the creation of SKAN, probably India's first not-for-profit entity in the private sector, exclusively for medical research.

The research for the projects will be done through reputed partners, and directly in-house. The strategic partner for Neurological research is the Centre for Brain Research (CBR) at Indian Institute Science, Bangalore (IISc). CBR is putting together a consortium to handle the first project on Parkinson's disease. The strategic partner for Ageing is the upcoming St. John's Geriatric Centre (SJGC), to be located on the St John's Hospital campus. Soota has agreed to fund the setting up of the Centre for Research in Ageing and Geriatrics (CRAG) at the SJGC and to support joint projects. In Ageing, the approach will be to go wide into relatively under-researched areas and will include the establishment of a large community-based research cohort. For Neurological research, the plan will be to go deep into select areas like Parkinson's disease, Bipolar disorders, Strokes and other Cerebrovascular disorders.

For problems related to both ageing and neurological disorders, the philosophy of the research will include searching for kinder, gentler therapies; delaying the onset and slowing down the progression of the disease and providing persons a better quality of life even as they live with the illness.

Soota also announced funds commitment of Rs.200 Crores for SKAN. Out of this, Rs 100 crores is earmarked for partners such as St John's, Centre for Brain Research (CBR), IIT-Roorkee, NIMHANS and any new partners which may be added. Rs.100 crores is earmarked for investments in SKAN and direct projects within SKAN.

Ashok Soota said, "It will take 10 years to build a world class institution for Ageing and Neurological research. I am grateful to two eminent leaders who have agreed to take charge as Chairpersons for the two divisions in case of an exigency to me if line leadership is not ready to take charge. I have had this exigency-based arrangement in every organization I started, be it MindTree or Happiest Minds."

SKAN is on the lookout for talent including CEOs for the Ageing and Neurological divisions and many other positions. Please visit SKANrt.in for the positions to be filled and send an email to [email protected].

Media Contact:

Murali : +91 80 48529053 / +91 97417 01002  
[email protected] 

Logo: https://mma.prnewswire.com/media/1480601/SKAN_Logo.jpg 

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.